Accelerated fractionation using the concomitant boost: a contribution of radiobiology to radiotherapy.

L. Peters

Abstract:

What problem does this paper attempt to address?

Lactobacillus Johnsonii Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats.

Juan Xu,Yongchang Zhou,Siyang Cheng,Yuling Zhao,Junkai Yan,Ying Wang,Wei Cai,Lu Jiang

DOI: https://doi.org/10.3390/metabo13101043

IF: 4.1

2023-01-01

Metabolites

Abstract:Parenteral nutrition (PN), a vital therapy for patients with intestinal failure, can lead to the development of parenteral nutrition-associated liver disease (PNALD). In this study, we aimed to investigate the role of Lactobacillus johnsonii (L. johnsonii) in a rat model of PNALD. Total parenteral nutrition (TPN)-fed rats were used to assess the role of L. johnsonii in liver steatosis, bile acid metabolism, gut microbiota, and hepatocyte apoptosis. We observed a depletion of L. johnsonii that was negatively correlated with the accumulation of glycochenodeoxycholic acid (GCDCA), a known apoptosis inducer, in rats subjected to TPN. L. johnsonii attenuated TPN-induced liver steatosis by inhibiting fatty acid synthesis and promoting fatty acid oxidation. TPN resulted in a decrease in bile acid synthesis and biliary bile secretion, which were partially restored by L. johnsonii treatment. The gut microbial profile revealed depletion of pathogenic bacteria in L. johnsonii-treated rats. L. johnsonii treatment reduced both hepatic GCDCA levels and hepatocyte apoptosis compared with the TPN group. In vitro, L. johnsonii treatment inhibited GCDCA-induced hepatocyte apoptosis via its bile salt hydrolase (BSH) activity. Our findings suggest that L. johnsonii protects against liver steatosis, bile acid dysregulation, and hepatocyte apoptosis in TPN-fed rats.
The Effect of Dipeptiven in Patients after Allogenic Hematologic Stem Cell Transplantation.

H Huang,LH Shou,Y Luo,JM Shi,XL Zhu,Z Cai,MF Lin

DOI: https://doi.org/10.1182/blood.v106.11.5371.5371

IF: 20.3

2005-01-01

Blood

Abstract:Total parenteral nutrition (TPN) is provided to patients undergoing allogenic hematologic stem cell transplantation (allo-HSCT) to help minimize nutritional consequences of both conditioning regimens as well as complications resulting from the procedure such as GVHD, VOD and so on, and glutamine could to improve the clinical course of patients after transplantation while given with parenteral nutrition as it is considered that it has stimulatory effects on lymphocytes and mucosa cells in vitro. In the study, we investigated the effect of dipeptiven, N(2)-L-Alanyl-L-Glutamine, which has dipeptides as free glutamine is rather unstable and poorly soluble, added to standard TPN preparations on complication and recovery of patients with allo-HSCT. 40 patients who suffered hematologic malignancies and received allo-HSCT were randomly assigned to receive either standard TPN (control group, n=20), or dipeptiven supplemented TPN (DPT group, n=20). The Bu/Cy2 regimen was used in conditioning with Bu (16mg/kg) plus Cy (120mg/kg) and all patients were given mycophenolate mofetil, CsA and MTX to prevent GVHD. The nutritiona support was started about 1 to 12 days after transplantation and 1.5ml/kg.d dipeptiven was added to the DPT group. During the period of nutritiona support, serum albumin, total protein, creatinine, total bilirubin, leukocytes, lymphocytes were monitored, and time to neutrophil engraftment, decrease of body weight, hospital stays, and other data related to hospital infection and acute GVHD were evaluated for all patients. As a result, the levels of serum albumin fell in the two groups on the 7-day, but on the 28-day those in the DPT group returned to normal and were significantly better than those in the control group (P<0.05). The total bilirubin and creatinine concentration did not change much. And lymphocytes of the patients in the DPT group recovered more rapidly than in the control group (P<0.05). There were less cases with clinical infection and microbial colonization in the DPT group than the control group (10 vs 16,11 vs 17, P<0.05). Also days for antibiotic requirements, days of diarrhea, changes of body weight and hospital stays reduced in the DPT group (16.5±10.6d vs 25.4±16.3d, 4.7±4.5d vs 8.2±6.0d, 2.0±2.0kg vs 3.3±1.6kg, 49.2±18.8d vs 58.0±20.2d, P<0.05, respectively). There were no different between the two groups of incidence of acute GVHD. In the conclusion, DPT-supplemented parenteral nutrition was beneficial in allo-HSCT patients for the nutritional status improving, the incidence of infection and damage of intestine, liver diminishing were all reduced, and the incidence of acute GVHD not increasing.
[Expression of S100A4 in esophageal squamous cell carcinoma and its relation to tumor invasion and metastasis].

Hong-Yan Zhang,Xian-zhao Zheng,X. Xuan,Xin-hua Wang,Feng Wang,Shan-shan Li

2010-07-01

Abstract:OBJECTIVE To study the role of S100A4 in the carcinogenesis, development, invasion and metastasis of esophageal squamous cell carcinoma. METHODS Immunohistochemistry was used to detect the expressions of S100A4, MMP-2 and E-cadherin proteins in 100 cases of surgically resected esophageal squamous cell carcinoma specimens. RT-PCR and Western blot were used to detect the expressions of S100A4 mRNA and protein in esophageal squamous cell carcinoma line EC-1 and TE-1. Boyden-chamber model in vitro was utilized to detect the invasion ability of EC-1 and TE-1 cells. RESULTS The positivity rate of S100A4 protein was 52.0% was in esophageal carcinoma tissues, significantly higher than that in normal tissues (26.0%) (P<0.01). The expression of S100A4 was related to tumor grading, invasive depth and lymph node metastasis (P<0.05). In esophageal carcinoma, the expression of S100A4 was positively correlated to MMP-2 expression (P<0.01), but inversely to E-cadherin expression (P<0.05). The expressions of S100A4 mRNA (0.894-/+0.021) and protein (0.897-/+0.053) in EC-1 cells were significantly higher than those in TE-1 (0.812-/+0.040 and 0.645-/+0.089, respectively, P<0.01), and the invasion ability of EC-1 cells was significantly higher than that of TE-1 cells (91.00-/+17.44 vs 61.80-/+11.10, P<0.01). CONCLUSION The overexpression of S100A4 in esophageal squamous cell carcinoma tissue and highly invasive EC-1 cells may contribute to the carcinogenesis, development, invasion and metastasis of esophageal squamous cell carcinoma.
Endoscopic Nasojejunal Feeding Tube Placement in Patients with Severe Hepatopancreatobiliary Diseases: a Retrospective Study of 184 Patients.

Feng Ji,Jing-Li Zhao,Xi Jin,Chun-Hua Jiao,Yu-Yao Hu,Qin-Wei Xu,Wei-Xing Chen

2010-01-01

Abstract:BACKGROUND:Total parenteral nutrition (TPN) has been recognized as the mainstay of nutritional support in patients with severe hepatopancreatobiliary (HPB) diseases for decades. However, recent studies advocate the utilization of endoscopic nasojejunal feeding tube placement (ENFTP), rather than the conventional approach. This study was designed to compare the clinical value of ENFTP and TPN in patients with severe HPB diseases.METHODS:Two groups of patients with severe HPB diseases were analyzed retrospectively. One group of 88 patients received ENFTP, and the other 96 received TPN. Routine blood levels, serum glucose and prealbumin, hepatic and renal function, serum lipid, and calcium were measured at baseline and after 1, 2, and 4 weeks of nutritional support. Also, complication rate, mortality, nutritional support time, mechanical ventilation time, mean length of time in intensive care unit, and duration of hospital stay were analyzed.RESULTS:After 4 weeks of nutritional support, the degree of recovery of red blood cells, prealbumin, and blood glucose was greater in the ENFTP than in the TPN group (P<0.05). Furthermore, the ENFTP group showed a lower incidence of septicemia, multiple organ dysfunction syndrome, peri-pancreatic infection, biliary infection, and nosocomial infection, in addition to shorter nutritional support time and hospital stay (P<0.05).CONCLUSIONS:ENFTP is much more effective than TPN in assisting patients with severe HPB diseases to recover from anemia, low prealbumin level, and high serum glucose, as well as in decreasing the rates of various infections (pulmonary infection excluded), multiple organ dysfunction syndrome rate, nutrition support time, and length of hospital stay. Therefore, ENFTP is safer and more economical for clinical application.
Efficacy of Ultrasound Microbubble-HGF Complex for Treating Hepatic Fibrosis and Its Relation with Perfusion Weighted Imaging

Shou-Hong Zhang,Ying Zhang,Kun-Ming Wen,Wei Wu,Wen-Yan Li

DOI: https://doi.org/10.17582/journal.pjz/2020.52.1.363.368

2019-01-01

Pakistan Journal of Zoology

Abstract:We explored the feasibility of treating liver fibrosis with human Hepatocyte Growth Factor (HGF) carried by biotinylated ultrasound microbubbles plus biotinlated cationic nano-liposome composites (Bio-MB+Bio-CNLP) in bile duct-ligated (BDL) rats. In addition, we investigated the staging of hepatic fibrosis by using Perfusion-Weighted Imaging (PWI). We established a BDL rat model of hepatic fibrosis. HGF carrier was administered through tail-vein injections. The gene therapy efficacy was evaluated in vivo. Before and after treatment the rats were examined with MR-PWI. The perfusion parameters of PWl were compared with the fibrosis stage. The total fibrous tissue in the liver of rats treated with HGF was lower than that in control group. The time-signal intensity curve (TIC) peak of liver parenchyma of rats with hepatic fibrosis was characterized by a slow wash-in -out. A correlation was found between the perfusion parameters and the stage of fibrosis. As the stage of fibrosis increased, the wash-in and -out rates decreased progressively. The use of Bio-MB+Bio-CNLP is an effective and novel vector for gene delivery in vivo. Further, we confirm that HGF represents a valid liver anti-fibrotic molecule. PWI might be an effective method for quantifying the severity of liver fibrosis.
Effects of HGF in Celsior Solution on Levels of INF-γ. IL-4 and IL-10 in a Rat Liver Transplantation Model

LI Tao,TANG Hua-mei,SUN Xing,QIU Guo-qiang,PENG Zhi-hai

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2010.07.013

2010-01-01

Abstract:Objective To explore the impact of recombinant human hepatocyte growth factor (rhHGF) in Celsior (CS) solution on the expression of INF-γ, IL-4 and IL-10 in a rat liver transplan-tation model. Methods After flushed with CS solution with addition of rhHGF (experimental group) or saline (control group), NHBD livers were stored at 4℃; for 16 h.then they were transplanted using the two-cuff technique with arterial reconstruction. The serum levels of INF-γ, IL-4 and IL-10 at lh after reperfusion were detected using ELISA. The INF-γ, IL-4 and IL-10 mRNA in the corresponding liver tissue were determined by RT-PCR. The 7-day survival rate was calculated and the histopatho-logical examination results were analyzed by hematoxylin and eosin staining. Results Compared with the control group, the experimental group showed lower INF-γ level and higher IL-4 and IL-10 levels in serum at 1 h after reperfusion (P<0. 05). The level of INF-γ mRNA in liver tissue was significant decreased at 1 h after reperfusion (P<0. 05) , and the level of IL-4 and IL-10 mRNA was significantly increased in the experimental group (P<0. 05). In experimental group, recipients got a better survival rate and histopathological examination showed a well-preserved hepatic architecture without hepatocyte necrosis, milder sinusoidal and portal congestion. Conclusion Adding exogenous rhHGF in CS solu-tion can protect NHBD livers from ischemia-reperfusion injury and prolong the survival in rats, which might be due to down-regulation of TNF-γ and up-regulation of IL-4 and IL-10.
Hydrogen-Rich Saline Attenuates Acute Hepatic Injury in Acute Necrotizing Pancreatitis by Inhibiting Inflammation and Apoptosis, Involving JNK and P38 Mitogen-Activated Protein Kinase–dependent Reactive Oxygen Species

Qiao Shi,Chen,Wen-hong Deng,Peng Wang,Teng Zuo,Liang Zhao,Jia Yu,Kai-liang Zhao,Fang-chao Mei,Chen Li,Gui-rong Wang,Wei-xing Wang

DOI: https://doi.org/10.1097/mpa.0000000000000678

2016-01-01

Pancreas

Abstract:Objectives The objective of this study was to study the role of hydrogen-rich saline (HRS) on acute hepatic injury (AHI) in acute necrotizing pancreatitis (ANP). Methods Rats were used for this study and an ANP model was induced by injecting 5% sodium taurocholate into the biliary-pancreatic duct. Experiments were performed in 3 groups: sham, ANP, and ANP + HRS (HRS). Animals were killed at 3, 12, and 24 hours after operation, and then blood and tissue samples were harvested. Various physiological, histological, and cellular and molecular parameters were analyzed. Results Analyses of serum, lipase, alanine transaminase, and aspartate aminotransferase indicated that ANP-induced AHI model was established successfully and HRS attenuated hepatic dysfunction. Hepatic superoxide dismutase and malondialdehyde levels showed HRS against oxidative stress. Cellular and molecular analyses including p-p38, p-JNK, p-ERK, and caspase-3, caspase-9, NF-&kgr;B, and TNF-&agr; in hepatic tissues revealed that HRS attenuated ANP-induced AHI by inhibiting apoptosis and phosphorylation of JNK and p38, as well as NF-&kgr;B activation. Conclusions Hydrogen-rich saline plays a protective role in ANP-induced AHI through inhibiting inflammation and apoptosis, involving JNK and p38 MAPK-dependent reactive oxygen species.
Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Lingjian Zhang,Yalei Zhao,Linxiao Fan,Kai Xu,Feiyang Ji,Zhongyang Xie,Xiaoxi Ouyang,Daxian Wu,Lanjuan Li

DOI: https://doi.org/10.1002/ptr.6299

IF: 6.388

2019-01-01

Phytotherapy Research

Abstract:Tectorigenin has received attention due to its antiproliferation, anti‐inflammatory, and antioxidant activities. In this study, we investigated the effects of tectorigenin on lipopolysaccharide (LPS)/D‐galactosamine(D‐GalN)‐induced fulminant hepatic failure (FHF) in mice and LPS‐stimulated macrophages (RAW 264.7 cells). Pretreatment with tectorigenin significantly reduced the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), histological injury, apoptosis, and the mortality of FHF mice, by suppressing the production of inflammatory cytokines such as TNF‐α and IL‐6. Tectorigenin also suppressed the activation of the inflammatory response in LPS‐stimulated RAW 264.7 cells. Tectorigenin‐induced protection is mediated through its mitigation of TLR4 expression, inhibition of mitogen‐activated protein kinase (MAPK) and nuclear factor‐κB (NF‐κB) pathway activation, and promotion of autophagy in FHF mice and LPS‐stimulated RAW 264.7 cells. Therefore, tectorigenin has therapeutic potential for FHF in mice via the regulation of TLR4/MAPK and TLR4/NF‐κB pathways and autophagy.
Attenuation Of Experimental Liver Fibrosis By Hepatocyte Growth Factor Gene Delivery Mediated By Adenovirus

Yin Xu,Fei Q. Zheng,Jia Fang,Qunwei Zhang,Yide Qin,Yang Liu,Renjie Yang,Bin Wu

2008-01-01

Abstract:The hepatocyte growth factor (HGF), originally identified and cloned as a potent mitogen for hepatocytes, has an essential part in the development and regeneration of the liver. In this study, HGF expression in vitro and in vivo was determined using ELISA. Rats were injected subcutaneously with CCl4 for eight weeks to induce liver fibrosis, and then divided randomly into groups for administration of various doses of adenovirus HGF (Ad-HGF) or vehicle. All rats were sacrificed 8 weeks after obtaining samples of serum and hepatic tissue. The results showed that glutamic oxaloacetic transaminase (GOT), glutamate pyruvate transaminase (GPT), total protein (TP), albumin (ALB), and total bilirubin (TBil) in serum were significantly recovered after gene therapy (P<0.05). Ad-HGF also attenuated the expression of TGF-beta 1 and the deposition of collagen. We conclude that intravenous administration of Ad-HGF may be useful for the treatment of fibrotic liver by promoting liver function recovery and collagenolytic capacities.
Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

Vinken, Mathieu

DOI: https://doi.org/10.1007/s00204-024-03773-8

2024-05-15

Archives of Toxicology

Abstract:Parenteral nutrition (PN) is typically administered to individuals with gastrointestinal dysfunction, a contraindication for enteral feeding, and a need for nutritional therapy. When PN is the only energy source in patients, it is defined as total parenteral nutrition (TPN). TPN is a life-saving approach for different patient populations, both in infants and adults. However, despite numerous benefits, TPN can cause adverse effects, including metabolic disorders and liver injury. TPN-associated liver injury, known as intestinal failure-associated liver disease (IFALD), represents a significant problem affecting up to 90% of individuals receiving TPN. IFALD pathogenesis is complex, depending on the TPN components as well as on the patient's medical conditions. Despite numerous animal studies and clinical observations, the molecular mechanisms driving IFALD remain largely unknown. The present study was set up to elucidate the mechanisms underlying IFALD. For this purpose, human liver spheroid co-cultures were treated with a TPN mixture, followed by RNA sequencing analysis. Subsequently, following exposure to TPN and its single nutritional components, several key events of liver injury, including mitochondrial dysfunction, endoplasmic reticulum stress, oxidative stress, apoptosis, and lipid accumulation (steatosis), were studied using various techniques. It was found that prolonged exposure to TPN substantially changes the transcriptome profile of liver spheroids and affects multiple metabolic and signaling pathways contributing to liver injury. Moreover, TPN and its main components, especially lipid emulsion, induce changes in all key events measured and trigger steatosis.

toxicology
Protection of recombinant human growth hormone on rat liver with severe acute pancreatitis

Zhaohui Zhong,Mai Zhou,Daqing Wang,Gangjun Jiao,Wuyi Deng,Xisheng Leng

DOI: https://doi.org/10.3760/cma.j.issn.1007-631X.2016.02.011

2016-01-01

Abstract:Objective To investigate the effect of recombinant human growth hormone (rhGH) on rat liver injury with severe acute pancreatitis.Methods Severe acute pancreatitis model was established by injection of sodium taurocholate into the pancreatobiliary duct in 40 male Sprague-Dawley rats.Rats were randomly divided into experiment group (n =20) and control group (n =20).Another 20 male SD rats injected saline served as negative control group.The experiment group were treated with subcutaneously injected rhGH for 3 days,1 U·kg-1 ·d-1.12 h and 24 h after operation,the level of ALT,AST,TNF-α,IL-1 β,SOD,MDA,endotoxin and D-lactate was detected respectively;the degree of live cell apoptosis and pathological score of pancreatic tissue were compared among these groups.Results In comparison with negative control group,the level of ALT,AST,TNF-α,IL-1β,MDA,endotoxin and D-lactate,the liver cell apoptosis index and pathological score of pancreatic tissuc were significantly higher in the control group and experiment group at 12 h and 24 h after operation (P ＜ 0.05).ALT,AST,TNF-α,endotoxin and D-lactate at 12 h and 24 h were significantly lower in the experiment group (P ＜ 0.05).MDA level significantly declined at 12 h and 24 h after operation in experiment group(P ＜ 0.05).Liver cell apoptosis index of the control group was higher than experiment group (P =0.003).Conclusion rhGH pretreatment relieves liver injury in rat with severe acute pancreatitis.
Hepatoprotective effect of globin digest on liver injury - Alcohol-induced acute liver injury in ICR mice

Feng Han,Yuka Sasakawa,Chizuko Fukuhama,Kyoichi Kagawa,Koichi Tsuneyama

2010-01-01

Abstract:Globin digest (GD) is a commercially available oligopeptide mixture derived from edible globin proteins that has been developed to effectively lower the serum triglyceride levels and to regulate dietary fat metabolism. In this study, the hepatoprotective effect of GD on alcohol-induced acute liver injury in ICR mice was examined. ICR mice were randomly divided into the following five groups : the negative control, positive control, low, middle and high dosages of GD. GD was administered orally to the mice at a dose of 0.165 g/kg, 0.330 g/kg or 0.990 g/kg daily. Thirty days later, 50% alcohol or distilled water (negative control) was administered orally to the mice at a dose of 12 mL/kg. The parameters in the liver and histopathological change of hepatic steatosis were examined at 12 h after alcohol administration. The triglyceride values of the middle and high dosages of GD were lower than the positive control value. The malondialdehyde values of all dosages of GD were lower than the positive control value. The values of glutathione peroxidase activities of all dosages of GD were higher than the positive control value. The histopathological values of hepatic steatosis of all dosages of GD were lower than the positive control value. These results indicate that GD exerts the hepatoprotective effect on alcohol-induced acute liver injury in ICR mice through the suppression of lipid accumulation and lipid peroxide generation in the liver.
[Preliminary Experimental Study on Treatment of Portal Hypertension with Auxiliary Partial Orthotopic Liver Transplantation].

Liu-bin Shi,Cheng-hong Peng,Shu-you Peng,Ying-bin Liu,Wei He,Bin Xu,Xiao-peng Chen,Ming-dong Bai,Yong Wang,Ze Tang

DOI: https://doi.org/10.3760/j.issn:1003-0603.2004.12.008

2004-01-01

Abstract:OBJECTIVE:To evaluate the therapeutic efficacy of auxiliary partial orthotopic liver transplantation (APOLT) on portal hypertension in liver cirrhosis with amelioration of portal vein congestion, changes in portal vein pressure and status of the graft.METHODS:The recipients were porcine model of biliary cirrhosis reproduced by ligation of the common bile duct. During transplantation, arterial blood pressure, central venous pressure were recorded. Buffer base, standard bicarbonate and pH of arterial blood samples were determined and analyzed in order to assess the impact of operation on the animals. The hemodynamics were also monitored. Color Doppler ultrasonographic examination was performed on recipients before operation, intra-operation and 7 days after operation, respectively. Portal vein pressure, blood bilirubin and variables of liver function were measured by using an autoanalyzer. Wedge biopsy specimens of each pig were obtained, stained with hematoxylin-eosin, and examined. Analysis of variance was performed. Otherwise non-parametric tests were used.RESULTS:Eight weeks after ligation of the common bile duct, biliary cirrhosis was reproduced in all the pigs, and histopathological examination of the liver specimen showed a large number of pseudo-lobules. In 6 pigs with hepatic cirrhosis liver transplantation was done. Five of the 6 (83.3%) animals survived for 7 days. One recipient died because of unsuccessful operation, the others showed stable hemodynamics during the operation. Seven days after transplantation, the blood flow of the two liver portal veins was observed by the use of color Doppler ultrasonography. It was found that the blood flow in the donor portal vein was much richer than that of native portal vein. The venous outflow of the graft was ample and smooth, and no thrombosis of the hepatic vein or portal vein was found. The variables, including alanine aminotransferase, aspartate aminotransferase, bilirubin and total bilirubin, were significantly improved 7 days after operation compared with pre-operative data. Portal pressure was found to be (20.76+/-2.42)cm H(2)O(1 cm H(2)O=0.098 kPa), (17.62+/-2.33)cm H(2)O and (14.72+/-2.25)cm H(2)O before the operation, during the operation, and 7 days after operation, respectively, and the difference was statistically significant(P<0.01). On the 7 days after transplantation, histopathological examination revealed evidence of damage with mild steatosis and sporadic necrotic hepatocytes and focal hepatic lobular degeneration in the graft, especially in the area around the central vein.CONCLUSION:APOLT is a hopeful option for the treatment of portal hypertension. This procedure can provide not only some improvement of the liver function but also decrease the pressure of portal vein.
Impaired Gut-Systemic Signaling Drives Total Parenteral Nutrition-Associated Injury

Miguel Guzman,Chandrashekhara Manithody,Joseph Krebs,Christine Denton,Sherri Besmer,Pranjali Rajalakshmi,Sonali Jain,Gustavo Adolfo Villalona,Ajay Kumar Jain

DOI: https://doi.org/10.3390/nu12051493

IF: 5.9

2020-05-20

Nutrients

Abstract:Background: Total parenteral nutrition (TPN) provides all nutritional needs intravenously. Although lifesaving, enthusiasm is significantly tempered due to side effects of liver and gut injury, as well as lack of mechanistic understanding into drivers of TPN injury. We hypothesized that the state of luminal nutritional deprivation with TPN drives alterations in gut-systemic signaling, contributing to injury, and tested this hypothesis using our ambulatory TPN model. Methods: A total of 16 one-week-old piglets were allocated randomly to TPN (n = 8) or enteral nutrition (EN, n = 8) for 3 weeks. Liver, gut, and serum were analyzed. All tests were two-sided, with a significance level of 0.05. Results: TPN resulted in significant hyperbilirubinemia and cholestatic liver injury, p = 0.034. Hepatic inflammation (cluster of differentiation 3 (CD3) immunohistochemistry) was higher with TPN (p = 0.021). No significant differences in alanine aminotransferase (ALT) or bile ductular proliferation were noted. TPN resulted in reduction of muscularis mucosa thickness and marked gut atrophy. Median and interquartile range for gut mass was 0.46 (0.30-0.58) g/cm in EN, and 0.19 (0.11-0.29) g/cm in TPN (p = 0.024). Key gut-systemic signaling regulators, liver farnesoid X receptor (FXR; p = 0.021), liver constitutive androstane receptor (CAR; p = 0.014), gut FXR (p = 0.028), G-coupled bile acid receptor (TGR5) (p = 0.003), epidermal growth factor (EGF; p = 0.016), organic anion transporter (OAT; p = 0.028), Mitogen-activated protein kinases-1 (MAPK1) (p = 0.037), and sodium uptake transporter sodium glucose-linked transporter (SGLT-1; p = 0.010) were significantly downregulated in TPN animals, whereas liver cholesterol 7 alpha-hydroxylase (CyP7A1) was substantially higher with TPN (p = 0.011). Conclusion: We report significant alterations in key hepatobiliary receptors driving gut-systemic signaling in a TPN piglet model. This presents a major advancement to our understanding of TPN-associated injury and suggests opportunities for strategic targeting of the gut-systemic axis, specifically, FXR, TGR5, and EGF in developing ameliorative strategies.
G‐protein‐Coupled Bile Acid Receptor Attenuates Liver Injury in a Murine Model of Acute Parenteral Nutrition

Charles Klazer Gomes,Prahlad Rao,Erin Stephenson,Michelle Puchowicz,Liza Makowski,Joan K. Han,Dengping Yin,Eugene B. Chang,Joseph F. Pierre

DOI: https://doi.org/10.1096/fasebj.2018.32.1_supplement.759.6

2018-04-01

The FASEB Journal

Abstract:Parenteral Nutrition (PN) provides essential caloric support in patients unable to feed enterally. Unfortunately, PN without enteral feeding is associated with hepatic injury, especially in neonates where PN associated liver disease (PNALD) affects 60–70% of recipients. PN alters intestinal physiology and host‐microbial interactions, including bile acid enterohepatic circulation, which regulates metabolism through nuclear and cell membrane bile acid receptors. Here, we examined the role of G‐protein coupled bile acid receptor deficiency (TGR5−/−) upon hepatic phenotype in a murine model of acute PN. TGR5−/− and wild type (WT) received PN for 96 hours. PN significantly elevated serum triglycerides, resistin, PAI‐1 and hepatic fatty acid synthesis gene expression in both genotypes. However, PN‐treated TGR5−/− animals had significantly larger liver weights compared with WT, but displayed no changes in triglycerides. Histological analysis instead suggested edema. Accordingly, TGR5−/− animals on PN displayed elevated hepatic IL‐6 expression and significantly higher serum AST and ALT levels compared with WT. Furthermore, TGR5−/− animals on PN also displayed significantly decreased bile acid synthesis genes, including Cyp7A1, Cyp8B1, Cyp7B1, and BAT, compared with WT. Therefore, we examined serum bile acid composition. PN elevated total conjugated primary bile acid levels, specifically TCA, TCDCA, TbMCA, and TaMCA, in both genotypes compared with chow. However, TGR5−/− on PN displayed markedly higher levels of the unconjugated primary bile acids, CDCA, aMCA, and the secondary bile acids, oMCA and DCA, compared with WT on PN. Predictive metagenomics of 16S sequencing suggested altered microbial enzymes in TGR5−/−, including BSH and 7alpha hydroxylase, consistent with serum bile acid changes. These results suggest a protective role for TGR5 in liver function during PN that potentially includes direct attenuation of hepatic inflammation or indirect manipulation through microbiota‐bile acid interactions. Greater mechanistic understanding of TGR5 signaling during PN might improve interventions to treat or prevent PNALD. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

cell biology,biochemistry & molecular biology,biology
Effects of parenteral nutrition supplemented with beta‐hydroxy‐beta‐methylbutyrate on gut‐associated lymphoid tissue and morphology in mice

Haruka Takayama,Kazuhiko Fukatsu,Midori Noguchi,Kazuya Takahashi,Ayako Watkins,Nana Matsumoto,Tomonori Narita,Satoshi Murakoshi

DOI: https://doi.org/10.1002/jpen.2686

2024-09-21

Journal of Parenteral and Enteral Nutrition

Abstract:Background Parenteral nutrition (PN) without enteral nutrition (EN) leads to marked atrophy of gut‐associated lymphoid tissue (GALT), causing mucosal defense failure in both the gut and the extraintestinal mucosal system. We evaluated the effects of beta‐hydroxy‐beta‐methylbutyrate (HMB) on GALT and gut morphology in PN‐fed mice. Methods Experiment 1: male Institute of Cancer Research mice were assigned to the Chow (n = 12), Control (standard PN: n = 10), or H600 and H2000 (PN containing 600 mg/kg or H2000 mg/kg body weight of Ca‐HMB: n = 12 and 10, respectively) groups. After 5 days of dietary manipulation, all mice were killed and the whole small intestine was harvested. GALT lymphocyte cell numbers and phenotypes of Peyer patch (PP), intraepithelial space, and lamina propria lymphocytes were evaluated. Experiment 2: 47 mice (Chow: n = 12; Control: n = 14; H600: n = 11; and H2000: n = 10) were fed for 5 days as in experiment 1. Proliferation and apoptosis of gut immune cells and mucosa, and protein expressions (mammalian target of rapamycin [mTOR], caspase‐3, and Bcl2) were evaluated in the small intestine. Results Compared with the Controls, the Chow and HMB groups showed significantly higher PP cell numbers, prevented gut mucosal atrophy, inhibited apoptosis of gut cells, and increased their proliferation in association with increased mTOR activity and Bcl2 expression. Conclusion HMB‐supplemented PN is a potentially novel method of preserving GALT mass and gut morphology in the absence of EN.

nutrition & dietetics
Glp-2 Prevents Intestinal Mucosal Atrophy And Improves Tissue Antioxidant Capacity In A Mouse Model Of Total Parenteral Nutrition

Qiucheng Lei,Jingcheng Bi,Xinying Wang,Tingting Jiang,Chao Wu,Feng Tian,Xuejin Gao,Xiao Wan,Huijun Zheng

DOI: https://doi.org/10.3390/nu8010033

IF: 5.9

2016-01-01

Nutrients

Abstract:We investigated the effects of exogenous glucagon-like peptide-2 (GLP-2) on mucosal atrophy and intestinal antioxidant capacity in a mouse model of total parenteral nutrition (TPN). Male mice (6-8 weeks old) were divided into three groups (n = 8 for each group): a control group fed a standard laboratory chow diet, and experimental TPN (received standard TPN solution) and TPN + GLP-2 groups (received TPN supplemented with 60 mu g/day of GLP-2 for 5 days). Mice in the TPN group had lower body weight and reduced intestinal length, villus height, and crypt depth compared to the control group (all p < 0.05). GLP-2 supplementation increased all parameters compared to TPN only (all p < 0.05). Intestinal total superoxide dismutase activity and reduced-glutathione level in the TPN + GLP-2 group were also higher relative to the TPN group (all p < 0.05). GLP-2 administration significantly upregulated proliferating cell nuclear antigen expression and increased glucose-regulated protein (GRP78) abundance. Compared with the control and TPN + GLP-2 groups, intestinal cleaved caspase-3 was increased in the TPN group (all p < 0.05). This study shows GLP-2 reduces TPN-associated intestinal atrophy and improves tissue antioxidant capacity. This effect may be dependent on enhanced epithelial cell proliferation, reduced apoptosis, and upregulated GRP78 expression.
Effects of Recombinant Human Growth Hormone on Acute Liver Injury Induced by Enterogenic Endotoxemia in Rats

LIN Ying,ZHU Xi,YAO Gai-qi,A La-ta,YANG Yan-lin

2011-01-01

Abstract:Objective To investigate the effects of recombinant human growth hormone(rh-GH) on acute liver injury induced by enterogenic endotoxemia in rats.Methods Sixty rats were randomly assigned into three groups(20 each): normal control group(NC group),intestinal obstruction and ischemia group(IOI group) and growth hormone group(GH group).Each group was divided again into two subgroups(10 each) according to different time intervals.The ileum and the mesenteric vessels were ligated to reproduce the IOI rat model(IOI group).rh-GH [2.25U/(kg d),i.m] was given to the IOI rats in GH group.The mean arterial blood pressure(MAP),alanine transaminase(ALT) and total bilirubin(TBIL) were measured at the 36th and 72nd hour after treatment.The level of endotoxin,tumor necrosis factor α(TNF-α) and interleukin-1β(IL-1β) in plasma were determined by limulus test and ELISA.The histopathological changes of the liver were observed at each time interval.Results Compared with NC group,MAP decreased markedly in IOI group at different time points(P0.05),while no obvious changes were found in GH group.The concentration of endotoxin in plasma was much higher in IOI group than in NC group at each time point,while increased only at the 36th hour after treatment in GH group(P0.05).The concentrations of TNF-α,IL-1β,ALT and TBIL in plasma were significantly increased in IOI and GH group than in NC group at each time point,while decreased in GH group compared with that in IOI group(P0.05).The histopathological changes in liver were obviously ameliorated in GH group than in IOI group at each time point.Conclusions rh-GH may obviously improve the function and histopathological changes in livers in IETM rats,and the results may be attributed to its function of ameliorating the severity of septic shock and reducing the endotoxin and inflammatory cytokines levels in plasma.
Hepatocyte growth factor mediates a novel form of hepatic stem/progenitor cell-induced tolerance in a rat xenogeneic liver rejection model

Quanyu Chen,Yu You,Yujun Zhang,Hongyu Zhang,Lianhua Bai

DOI: https://doi.org/10.1016/j.intimp.2020.107180

IF: 5.714

2021-01-01

International Immunopharmacology

Abstract:We have previously identified novel neural/glial antigen 2-expressing hepatic stem/progenitor cells (NG2+ HSPs) that are beneficial for tissue repair by inhibiting the immune cell response. In this in vivo study, we investigated the use of hepatocyte growth factor (HGF)-secreting NG2+ HSPs as a tolerogen in the well-established Syrian golden hamster (SGH) to Lewis (LEW) xenogeneic rat acute liver rejection (ARJ) model. Liver and blood cells were collected for histology and functional analyses using immunofluorescence staining, western blot, ELISA, and TUNEL assays. All recipient rats were randomly divided into 5 groups (n = 14 rats/group) and treated with: (1) ARJ + PBS: (2) ARJ + NG2: tail vein injection of NG2+ HSPs; (3) ARJ + tacrolimus (FK506, oral administration); (4) ARJ + an anti-cMet functional blocking antibody (a-cMet-Ab, I.V) 24 h before the injection of NG2+ HSPs; (5) ARJ + cHGF (clinically used HGF). LEW to LEW syngeneic rats were considered "normal" (n = 14, namely Syn). Significantly prolonged mean survival times (MSTs) and improved graft functions were observed after NG2+ HSP transplantation. An anti-cMet Ab significantly blocked the effect of NG2+ HSPs, suggesting that the effects were likely associated with HGF secreted from NG2+ HSPs. Notably, when intravenously injected into the xenogeneic rat model, the injected cHGF not only prolonged the MST of recipient rats but also increased the number of TUNEL-expressing xenoreactive cytotoxic T lymphocytes (CD8+ T cells). Based on these results, HGF-secreting NG2+ HSPs may specifically target recipient CD8+ T cells by inducing their apoptosis.

pharmacology & pharmacy,immunology
Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis

Gulisudumu Maitiabula,Feng Tian,Peng Wang,Li Zhang,Xuejin Gao,Songlin Wan,Haifeng Sun,Jianbo Yang,Yupeng Zhang,Tingting Gao,Bin Xue,Chaojun Li,Jieshou Li,Xinying Wang

DOI: https://doi.org/10.1016/j.jcmgh.2022.05.008

IF: 8.797

2022-01-01

Cellular and Molecular Gastroenterology and Hepatology

Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS">Parenteral nutrition (PN) is a lifesaving therapy for patients with intestinal failure. Hepatic steatosis is a potentially fatal complication of long-term PN, but the involved pathological mechanisms are incompletely unclarified. Herein, we identify the role of protein phosphatase 2A (PP2A) in the pathogenesis of parenteral nutrition-associated hepatic steatosis (PNAHS).</AbstractText>METHODS: <AbstractText Label="METHODS">Proteomic/phosphoproteomic analyses of liver samples from patients with PNAHS were applied to identify the mechanism of PNAHS. Total parenteral nutrition (TPN) mice model, in vivo, and in vitro experiments were used to assess the effect of PP2A-Cα on liver fatty acid metabolism.</AbstractText>RESULTS: <AbstractText Label="RESULTS">Reduced expression of PP2A-Cα (catalytic subunit) enhanced activation of serine/threonine kinase Akt2 and decreased activation of adenosine monophosphate-activated protein kinase (AMPK) were associated with hepatic steatosis in patients with PNAHS. Mice given PN for 14 days developed hepatic steatosis, down-regulation of PP2A-Cα, activation of Akt2, and inhibition of AMPK. Hepatocyte-specific deletion of PP2A-Cα in mice given PN exacerbated Akt2 activation, AMPK inhibition, and hepatic steatosis through an effect on fatty acid degradation, whereas hepatocyte-specific PP2A-Cα overexpression significantly ameliorated hepatic steatosis accompanied with Akt2 suppression and AMPK activation. Additionally, pharmacological activation of Akt2 in mice overexpressing PP2A-Cα led to the aggravation of hepatic steatosis.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">Our findings demonstrate that hepatic PP2A-Cα serves as a protective factor of PNAHS due to ameliorating hepatic steatosis and improving liver function. Our study provides a strong rationale that PP2A-Cα may be involved in the pathogenesis of PNAHS.</AbstractText>

gastroenterology & hepatology

Accelerated fractionation using the concomitant boost: a contribution of radiobiology to radiotherapy.

Lactobacillus Johnsonii Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats.

The Effect of Dipeptiven in Patients after Allogenic Hematologic Stem Cell Transplantation.

[Expression of S100A4 in esophageal squamous cell carcinoma and its relation to tumor invasion and metastasis].

Endoscopic Nasojejunal Feeding Tube Placement in Patients with Severe Hepatopancreatobiliary Diseases: a Retrospective Study of 184 Patients.

Efficacy of Ultrasound Microbubble-HGF Complex for Treating Hepatic Fibrosis and Its Relation with Perfusion Weighted Imaging

Effects of HGF in Celsior Solution on Levels of INF-γ. IL-4 and IL-10 in a Rat Liver Transplantation Model

Hydrogen-Rich Saline Attenuates Acute Hepatic Injury in Acute Necrotizing Pancreatitis by Inhibiting Inflammation and Apoptosis, Involving JNK and P38 Mitogen-Activated Protein Kinase–dependent Reactive Oxygen Species

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Attenuation Of Experimental Liver Fibrosis By Hepatocyte Growth Factor Gene Delivery Mediated By Adenovirus

Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

Protection of recombinant human growth hormone on rat liver with severe acute pancreatitis

Hepatoprotective effect of globin digest on liver injury - Alcohol-induced acute liver injury in ICR mice

[Preliminary Experimental Study on Treatment of Portal Hypertension with Auxiliary Partial Orthotopic Liver Transplantation].

Impaired Gut-Systemic Signaling Drives Total Parenteral Nutrition-Associated Injury

G‐protein‐Coupled Bile Acid Receptor Attenuates Liver Injury in a Murine Model of Acute Parenteral Nutrition

Effects of parenteral nutrition supplemented with beta‐hydroxy‐beta‐methylbutyrate on gut‐associated lymphoid tissue and morphology in mice

Glp-2 Prevents Intestinal Mucosal Atrophy And Improves Tissue Antioxidant Capacity In A Mouse Model Of Total Parenteral Nutrition

Effects of Recombinant Human Growth Hormone on Acute Liver Injury Induced by Enterogenic Endotoxemia in Rats

Hepatocyte growth factor mediates a novel form of hepatic stem/progenitor cell-induced tolerance in a rat xenogeneic liver rejection model

Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis